Position in AZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$795,946,446
-$113,469,684 QoQ
Shares Held
4,197,587
-9.0% QoQ
Ownership
0.271%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#46
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $40,525,577,269 across 9 Drug Manufacturers - General names. AZN ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,873,140 | $25,035,872,397 | |
| 2 | ABBV |
AbbVie Inc.
|
30,101,551 | $7,574,754,293 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
19,393,296 | $2,450,149,016 | |
| 4 | AMGN |
Amgen Inc
|
6,272,625 | $2,271,442,965 | |
| 5 | JNJ |
Johnson & Johnson
|
8,164,545 | $2,073,549,493 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
4,197,587 | $795,946,446 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,925,013 | $247,364,170 | |
| 8 | SNY |
Sanofi
|
1,677,399 | $71,557,841 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $795,946,446 | 4,197,587 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $909,416,130 | 4,611,176 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||